Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapeutic use. Found 398 abstracts

no pagination
Manne SL, Ostroff JS, Winkel G, Fox K, Grana G, Miller E, Ross S, Frazier T, Buyyounouski MK, Hanlon AL, Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG, Pollack A, Morrow M, Chen JQ, Yager JD, Russo J, Bassi DE, Fu J, Lopez de Cicco R, Klein-Szanto AJ, Devlin J, Sherman E, Altomare DA, Vaslet CA, Skele KL, De Rienzo A, Devarajan K, Jhanwar SC, McClatchey AI, Kane AB, Testa JR, Murphy ME, Langer CJ, Mehta MP, Viterbo R, Greenberg RE, Al-Saleem T, Canutescu AA, Dunbrack RL, Serebriiskii IG, Fang R, Latypova E, Hopkins R, Vinson C, Joung JK, Golemis EA. Couple-focused group intervention for women with early stage breast cancer. . J Consult Clin Psychol. 2005 Sep 15;73(4):634-46.
Ozols RF. Gemcitabine and carboplatin in second-line ovarian cancer. Semin Oncol. 2005 Aug;32(4 Suppl 6):S4-8.
Berger AC, Watson JC, Ross EA, Zalatoris A, Hoffman JP. Neoadjuvant therapy and biliary decompression lower biliary and pancreatic juice vascular endothelial growth factor levels in patients with periampullary adenocarcinoma. Am Surg. 2004 Feb;70(2):169-73; discussion 173-4.
Langer CJ. Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: focus on NSCLC. Int J Radiat Oncol Biol Phys. 2004 Mar;58(3):991-1002.
Balkwill F, Bast RC, Berek J, Chenevix-Trench G, Gore M, Hamilton T, Jacobs I, Mills G, Souhami R, Urban N, Ursulic S, Smyth J. Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust. Eur J Cancer. 2003 Sep;39(13):1818-27.
Brown TA, Ridge JA, Goldberg M. Gastrostomy-site tumor recurrence is not always fatal. Surgical endoscopy. 2003 Feb;17(2):351.
Cohen SJ, Ho L, Ranganathan S, Abbruzzese JL, Alpaugh RK, Beard M, Lewis NL, McLaughlin S, Rogatko A, Perez-Ruixo JJ, Thistle AM, Verhaeghe T, Wang H, Weiner LM, Wright JJ, Hudes GR, Meropol NJ. Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma. J Clin Oncol. 2003 Apr;21(7):1301-6.
Conejo-Garcia JR, Benencia F, Courreges MC, Khang E, Zhang L, Mohamed-Hadley A, Vinocur JM, Buckanovich RJ, Thompson CB, Levine B, Coukos G. Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells. Cancer Biol Ther. 2003 Jul;2(4):446-51.
D'Souza WD, Lee HK, Palmer MB, Smith LG, Pollack A. Is intraoperative nomogram-based overplanning of prostate implants necessary?. Int J Radiat Oncol Biol Phys. 2003 Jun;56(2):462-7.
Eisenberg BL. Imatinib mesylate: a molecularly targeted therapy for gastrointestinal stromal tumors. Oncology (Huntingt). 2003 Nov;17(11):1615-20; discussion 1620, 1623, 1626 passim.
Eisenberg BL, von Mehren M. Pharmacotherapy of gastrointestinal stromal tumours. Expert Opin Pharmacother. 2003 Jun;4(6):869-74.
Haas NB, Smith M, Lewis N, Littman L, Yeslow G, Joshi ID, Murgo A, Bradley J, Gordon R, Wang H, Rogatko A, Hudes GR. Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study. Clin Cancer Res. 2003 Jan;9(1):109-14.
Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E, Schilsky RL, Wood WC, Muss HB, Norton L. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol. 2003 Mar 15;21(6):976-83.
Jett JR, Scott WJ, Rivera MP, Sause WT. Guidelines on treatment of stage IIIB non-small cell lung cancer. Chest. 2003 Jan;123(1 Suppl):221S-225S.
Langer CJ. The global role of irinotecan in the treatment of lung cancer: 2003 update. Oncology (Huntingt). 2003 Jul;17(7 Suppl 7):30-40.
Laport GG, Levine BL, Stadtmauer EA, Schuster SJ, Luger SM, Grupp S, Bunin N, Strobl FJ, Cotte J, Zheng Z, Gregson B, Rivers P, Vonderheide RH, Liebowitz DN, Porter DL, June CH. Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation. Blood. 2003 Sep 15;102(6):2004-13.
Lee HK, D'Souza WD, Yamal JM, Pollack A, Lee AK, Palmer MB, Kuban DA. Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2003 Oct;57(2):355-61.
Meyers MO, Sasson AR, Sigurdson ER. Locoregional strategies for colorectal hepatic metastases. Clin Colorectal Cancer. 2003 May;3(1):34-44.
Meyers MO, Watson JC. Angiogenesis and hepatic colorectal metastases. Surg Oncol Clin N Am. 2003 Jan;12(1):151-63.
Nguyen KH, Horwitz EM, Hanlon AL, Uzzo RG, Pollack A. Does short-term androgen deprivation substitute for radiation dose in the treatment of high-risk prostate cancer?. Int J Radiat Oncol Biol Phys. 2003 Oct;57(2):377-83.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapeutic use

therapeutic use Human drug therapy Antineoplastic Agents Female Male pathology administration & dosage Aged methods therapy metabolism surgery Adult secondary Antineoplastic Combined Chemotherapy Protocols Middle Age US Gov't Support-PHS Treatment Outcome pharmacology Brachytherapy genetics antagonists & inhibitors Neoadjuvant Therapy Combined Modality Therapy Radiotherapy Dosage Middle Aged Ovarian Neoplasms immunology radiotherapy Lung Neoplasms Disease-Free Survival Adjuvant Chemotherapy Enzyme Inhibitors 80 and over Aged mortality Analysis of Variance blood Amino Acid Sequence Gastrointestinal Neoplasms Proportional Hazards Models Survival Rate Adenocarcinoma Randomized Controlled Trials analysis Cisplatin Neoplasm Metastasis Remission Induction Pyrimidines Colorectal Neoplasms radiography Kidney Neoplasms Non-US Gov't Research Support Deoxycytidine Local Neoplasm Recurrence Urethra Clinical Trials Amino Acid Sequence Homology United States Non-Small-Cell Lung Carcinoma Piperazines Pancreatic Neoplasms X-Ray Computed Tomography Liver Neoplasms Molecular Sequence Data Prostatic Neoplasms Non-US Gov't Support Etoposide Adjuvant Radiotherapy chemistry Neoplasm Staging analogs & derivatives Phase III Clinical Trials Iodine Radioisotopes drug effects Disease Progression Adrenal Gland Neoplasms Survival Analysis 0 (Proteins) Antigen Receptors-T-Cell Camptothecin Matched-Pair Analysis Tretinoin toxicity Drug Delivery Systems Adrenal Cortex Hormones Recombinant Fusion Proteins Molecular Models Breast Neoplasms CD8-Positive T-Lymphocytes Seizures Dose Fractionation EC 27137 (Proto-Oncogene Proteins c-raf) transplantation Two-Hybrid System Techniques Nonparametric Statistics User-Computer Interface C-Reactive Protein Interleukin-2 Hematopoietic Stem Cell Transplantation Rectum Systems Integration dosage US Gov't Research Support-PHS Carrier Proteins Radiometry Follow-Up Studies Growth Substances Palliative Care Paclitaxel DNA-Binding Proteins Liver etiology Anthracycline Antibiotics biosynthesis Three-Dimensional Imaging adverse Epidermal Growth Factor Receptor Algorithms Brain Neoplasms physiopathology 0 (Recombinant Fusion Proteins) Colonic Neoplasms Japan Catheter Ablation Alkyl and Aryl Transferases Immunoglobulin G 0 (Adrenal Cortex Hormones) Urinary Catheterization Cognition Disorders effects Retrospective Studies Hepatectomy Quinazolines Ligands Adolescent Prognosis Survival Neoplasm Drug Resistance Phytogenic Antineoplastic Agents Fluorouracil Stomach Neoplasms Proteins Cytarabine T-Lymphocytes Protein Interaction Mapping BRCA2 Genes Bile Androgen Antagonists Phospholipase C
Last updated on Wednesday, February 05, 2020